Dolors Puigdemont

2.7k total citations
48 papers, 2.0k citations indexed

About

Dolors Puigdemont is a scholar working on Pharmacology, Experimental and Cognitive Psychology and Cognitive Neuroscience. According to data from OpenAlex, Dolors Puigdemont has authored 48 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pharmacology, 13 papers in Experimental and Cognitive Psychology and 12 papers in Cognitive Neuroscience. Recurrent topics in Dolors Puigdemont's work include Treatment of Major Depression (19 papers), Functional Brain Connectivity Studies (11 papers) and Neurological disorders and treatments (9 papers). Dolors Puigdemont is often cited by papers focused on Treatment of Major Depression (19 papers), Functional Brain Connectivity Studies (11 papers) and Neurological disorders and treatments (9 papers). Dolors Puigdemont collaborates with scholars based in Spain, Switzerland and Germany. Dolors Puigdemont's co-authors include Víctor Pérez, Enric Álvarez, Marı́a J. Portella, Javier de Diego-Adeliño, Rosario Pérez‐Egea, Joaquim Soler, Juan Carlos Pascual, Maria Serra-Blasco, Beatriz Gómez‐Ansón and Yolanda Vives‐Gilabert and has published in prestigious journals such as American Journal of Psychiatry, The British Journal of Psychiatry and British Journal of Pharmacology.

In The Last Decade

Dolors Puigdemont

48 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dolors Puigdemont Spain	23	503	477	473	454	392	48	2.0k
Andreas Erfurth Germany	27	488 1.0×	428 0.9×	556 1.2×	1.3k 2.8×	444 1.1×	139	2.6k
Sakina J. Rizvi Canada	26	650 1.3×	651 1.4×	378 0.8×	720 1.6×	610 1.6×	63	2.8k
Hisanobu Kaiya Japan	25	340 0.7×	468 1.0×	393 0.8×	410 0.9×	163 0.4×	120	1.9k
Stephanie Krüger Germany	22	514 1.0×	627 1.3×	252 0.5×	1.1k 2.4×	451 1.2×	59	2.4k
Meng Li China	28	490 1.0×	1.0k 2.2×	232 0.5×	277 0.6×	201 0.5×	113	2.3k
Corinde E. Wiers United States	30	346 0.7×	1.2k 2.6×	845 1.8×	314 0.7×	268 0.7×	107	3.0k
Min-Soo Lee South Korea	24	329 0.7×	585 1.2×	413 0.9×	458 1.0×	396 1.0×	72	2.0k
Berend Malchow Germany	27	517 1.0×	797 1.7×	359 0.8×	1.3k 2.8×	171 0.4×	86	3.2k
Angela Merkl Germany	21	331 0.7×	364 0.8×	231 0.5×	290 0.6×	236 0.6×	38	1.3k
Tim A. Kimbrell United States	26	439 0.9×	1.3k 2.7×	319 0.7×	887 2.0×	272 0.7×	48	2.8k

Countries citing papers authored by Dolors Puigdemont

Since Specialization

Citations

This map shows the geographic impact of Dolors Puigdemont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dolors Puigdemont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dolors Puigdemont more than expected).

Fields of papers citing papers by Dolors Puigdemont

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dolors Puigdemont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dolors Puigdemont. The network helps show where Dolors Puigdemont may publish in the future.

Co-authorship network of co-authors of Dolors Puigdemont

This figure shows the co-authorship network connecting the top 25 collaborators of Dolors Puigdemont. A scholar is included among the top collaborators of Dolors Puigdemont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dolors Puigdemont. Dolors Puigdemont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vicent-Gil, Muriel, Dolors Puigdemont, Javier de Diego-Adeliño, et al.. (2022). Randomized clinical trial of integral cognitive remediation program for major depression (INCREM). Journal of Affective Disorders. 310. 189–197. 10 indexed citations

Corripio, Iluminada, Alexandra Roldán, Salvador Sarró, et al.. (2020). Deep brain stimulation in treatment resistant schizophrenia: A pilot randomized cross-over clinical trial. EBioMedicine. 51. 102568–102568. 61 indexed citations

Vives‐Gilabert, Yolanda, et al.. (2020). Glutamatergic and GABA-ergic abnormalities in First-episode depression. A 1-year follow-up 1H-MR spectroscopic study. Journal of Affective Disorders. 266. 572–577. 39 indexed citations

Vicent-Gil, Muriel, Anabel Martínez‐Arán, Caterina del Mar Bonnín, et al.. (2019). Testing the efficacy of INtegral Cognitive REMediation (INCREM) in major depressive disorder: study protocol for a randomized clinical trial. BMC Psychiatry. 19(1). 135–135. 6 indexed citations

Justicia, Azucena, Matilde Elices, Ana Isabel Cebrià, et al.. (2017). Rationale and methods of the iFightDepression study: A double-blind, randomized controlled trial evaluating the efficacy of an internet-based self-management tool for moderate to mild depression. BMC Psychiatry. 17(1). 143–143. 7 indexed citations

Trujols, Joan, Javier de Diego-Adeliño, Albert Feliu‐Soler, et al.. (2014). The Spanish version of the Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR16): A psychometric analysis in a clinical sample. Journal of Affective Disorders. 169. 189–196. 13 indexed citations

Diego-Adeliño, Javier de, Patrícia da Silva Pires, Beatriz Gómez‐Ansón, et al.. (2013). Microstructural white-matter abnormalities associated with treatment resistance, severity and duration of illness in major depression. Psychological Medicine. 44(6). 1171–1182. 121 indexed citations

Diego-Adeliño, Javier de, Marı́a J. Portella, Beatriz Gómez‐Ansón, et al.. (2013). Hippocampal abnormalities of glutamate/glutamine, N-acetylaspartate and choline in patients with depression are related to past illness burden. Journal of Psychiatry and Neuroscience. 38(2). 107–116. 56 indexed citations

Pérez-Caballero, Laura, Rosario Pérez‐Egea, Carmen Romero‐Grimaldi, et al.. (2013). Early responses to deep brain stimulation in depression are modulated by anti-inflammatory drugs. Molecular Psychiatry. 19(5). 607–614. 63 indexed citations

10.

Serra-Blasco, Maria, Marı́a J. Portella, Beatriz Gómez‐Ansón, et al.. (2013). Effects of illness duration and treatment resistance on grey matter abnormalities in majordepression. The British Journal of Psychiatry. 202(6). 434–440. 68 indexed citations

11.

Scorza, M.C., Laia Lladó-Pelfort, Roser Cortés, et al.. (2011). Preclinical and clinical characterization of the selective 5‐HT_1Areceptor antagonist DU‐125530 for antidepressant treatment. British Journal of Pharmacology. 167(5). 1021–1034. 38 indexed citations

12.

Soria, Virginia, Èrika Martínez‐Amorós, Geòrgia Escaramís, et al.. (2010). Differential Association of Circadian Genes with Mood Disorders: CRY1 and NPAS2 are Associated with Unipolar Major Depression and CLOCK and VIP with Bipolar Disorder. Neuropsychopharmacology. 35(6). 1279–1289. 270 indexed citations

13.

García‐Sevilla, Jesús A., Rebeca Dı́ez-Alarcia, Alfredo Ramos‐Miguel, et al.. (2010). Reduced platelet G protein-coupled receptor kinase 2 in major depressive disorder: Antidepressant treatment-induced upregulation of GRK2 protein discriminates between responder and non-responder patients. European Neuropsychopharmacology. 20(10). 721–730. 22 indexed citations

14.

Portella, Marı́a J., Javier de Diego-Adeliño, Beatriz Gómez‐Ansón, et al.. (2010). Ventromedial prefrontal spectroscopic abnormalities over the course of depression: A comparison among first episode, remitted recurrent and chronic patients. Journal of Psychiatric Research. 45(4). 427–434. 84 indexed citations

15.

Portella, Marı́a J., Javier de Diego-Adeliño, Javier Ballesteros, et al.. (2010). Can We Really Accelerate and Enhance the Selective Serotonin Reuptake Inhibitor Antidepressant Effect?. The Journal of Clinical Psychiatry. 72(7). 962–969. 50 indexed citations

16.

Pascual, Juan Carlos, Joaquim Soler, Dolors Puigdemont, et al.. (2008). Ziprasidone in the Treatment of Borderline Personality Disorder. The Journal of Clinical Psychiatry. 69(4). 603–608. 46 indexed citations

17.

Barrachina, Judith, et al.. (2007). Impresión clínica global para pacientes con trastorno límite de la personalidad (ICG-TLP): una escala sensible al cambio. Actas Españolas de Psiquiatría. 35(4). 229–235. 1 indexed citations

18.

Soler, Joaquim, Juan Carlos Pascual, Judith Barrachina, et al.. (2005). Double-Blind, Placebo-Controlled Study of Dialectical Behavior Therapy Plus Olanzapine for Borderline Personality Disorder. American Journal of Psychiatry. 162(6). 1221–1224. 134 indexed citations

19.

García‐Sevilla, Jesús A., Víctor Pérez, Dolors Puigdemont, et al.. (2003). Regulation of Platelet α2A-Adrenoceptors, Gi Proteins and Receptor Kinases in Major Depression: Effects of Mirtazapine Treatment. Neuropsychopharmacology. 29(3). 580–588. 40 indexed citations

20.

Pérez, Víctor, et al.. (1997). Estudio de validación del Center for Epidemiologic Studies-Depression (CES-D) en una población española de pacientes con trastornos afectivos.. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact